ARTICLES BY THIS AUTHOR
- 9/23/2020
The before and after of our lives
- 9/23/2020
Key clinical guidelines and statements – June to August, 2020
Most recent updates include resources on cannabis in adolescents, corticosteroids for bronchopulmonary dysplasia in preterm infants, COVID-19, dementia, diabetes-low carbohydrate diets, influenza 2020/21, naloxone, obesity, pulmonary arterial hypertension, syncope, ventricular tachycardia/fibrillation. - 9/23/2020
Rexall in PPN partnership with Reformulary Group
A preferred pharmacy network (PPN) partnership between Reformulary Group and Rexall offers drug plan sponsors and their members access to exclusive savings on Rexall-branded products. - 9/23/2020
Women and children first
- 9/23/2020
Emgality (galcanezumab) now indicated to reduce cluster headache frequency
CGRP binding antibody is first drug approved by Health Canada to help prevent episodic cluster headaches - 9/22/2020
Drug Safety: Health Canada must act faster when approved medications show risks
Despite monitoring the same drugs, Australia, Canada, the United Kingdom and the United States issued the same drug warnings only seven per cent of the time over a 10-year period.